In this file photo a bottle reading "Vaccine COVID-19" next to US pharmaceutical company Pfizer and German biotechnology company BioNTech logos is viewed on Nov 23, 2020. (JOEL SAGET / AFP)

NEW YORK - The Chinese mainland is planning to approve its first foreign COVID-19 vaccine before July, according to people privy to the matter, US media reported.

The clinical-trial data of the vaccine made by Germany's BioNTech SE has been under scrutiny, The Wall Street Journal reported on Friday, adding that the domestic distribution of the shot is expected to be given green light within the the next ten weeks.

READ MORE: Chile says Sinovac vaccine 67% effective in preventing infection

BioNTech has agreed to cooperate with Shanghai Fosun Pharma to deliver 100 million doses to the mainland in 2021, pending approval, according to the report. 

ALSO READ: J&J clot reports further strain vaccine drive